GROUP ONE TRADING, L.P. - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is and the CUSIP is 83587F952. A total of 4 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$130,774
-50.3%
147,600
-11.8%
0.00%
-100.0%
Q3 2022$263,000
-40.1%
167,300
-23.4%
0.00%0.0%
Q2 2022$439,000
+31.4%
218,500
+52.5%
0.00%
Q1 2022$334,000
-73.0%
143,300
-46.1%
0.00%
-100.0%
Q4 2021$1,236,000
-45.5%
265,700
-10.6%
0.00%
-50.0%
Q3 2021$2,268,000
-5.9%
297,200
+19.5%
0.00%
-33.3%
Q2 2021$2,409,000
-12.0%
248,600
-24.9%
0.00%
-25.0%
Q1 2021$2,739,000
-45.3%
331,200
-54.8%
0.00%
-55.6%
Q4 2020$5,006,000
-46.1%
733,500
-11.9%
0.01%
-69.0%
Q3 2020$9,283,000
+296.9%
832,600
+123.5%
0.03%
+163.6%
Q2 2020$2,339,000
+843.1%
372,500
+175.9%
0.01%
+450.0%
Q1 2020$248,000
-70.7%
135,000
-46.1%
0.00%
-66.7%
Q4 2019$846,000
+237.1%
250,300
+113.0%
0.01%
+200.0%
Q3 2019$251,000
-44.8%
117,500
-31.1%
0.00%
-50.0%
Q2 2019$455,000
-17.1%
170,500
+47.6%
0.00%
-33.3%
Q1 2019$549,000
+510.0%
115,500
+207.2%
0.01%
+500.0%
Q4 2018$90,000
-80.6%
37,600
-64.4%
0.00%
-75.0%
Q3 2018$465,000
-86.4%
105,600
-77.7%
0.00%
-86.2%
Q2 2018$3,407,000
+828.3%
473,200
+564.6%
0.03%
+625.0%
Q1 2018$367,000
+1647.6%
71,200
+1171.4%
0.00%
Q4 2017$21,000
+10.5%
5,600
+19.1%
0.00%
Q1 2017$19,000
-17.4%
4,7000.0%0.00%
Q4 2016$23,000
+228.6%
4,700
+261.5%
0.00%
Q2 2016$7,000
-80.0%
1,300
-80.0%
0.00%
Q1 2016$35,000
-71.8%
6,500
-54.2%
0.00%
-100.0%
Q4 2015$124,000
+85.1%
14,200
+77.5%
0.00%0.0%
Q3 2015$67,000
+272.2%
8,000
+700.0%
0.00%
Q2 2015$18,000
-90.2%
1,000
-93.7%
0.00%
-100.0%
Q1 2015$184,00015,9000.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 9,164$6,254,0001.20%
Athanor Capital, LP 150,000$1,024,0000.02%
GROUP ONE TRADING, L.P. 733,500$5,006,0000.01%
SIMPLEX TRADING, LLC 3,306$2,256,0000.00%
IMC-Chicago, LLC 257,700$1,759,0000.00%
JPMORGAN CHASE & CO 39,500$270,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders